...
首页> 外文期刊>Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists >Aplastic anemia and immune-mediated thrombocytopenia: concurrent complications encountered in the third trimester of pregnancy.
【24h】

Aplastic anemia and immune-mediated thrombocytopenia: concurrent complications encountered in the third trimester of pregnancy.

机译:再生障碍性贫血和免疫介导的血小板减少症:妊娠晚期并发并发症。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Aplastic anemia has been described rarely in pregnancy. The etiology is uncertain, and the treatment of choice, bone marrow transplant, is contraindicated in pregnancy. Thus, the occurrence of this complication during gestation presents a management challenge. Concurrent immune-mediated thrombocytopenia further complicates an already complex situation. CASE: Our patient with aplastic anemia and immune-mediated thrombocytopenia was diagnosed during the third trimester of pregnancy and treated with prednisone/high-dose intravenous (i.v.) immunoglobulin (Ig) and multiple transfusions of packed red blood cells and platelets. Fetal surveillance included twice-weekly non-stress tests coupled with sequential sonographic pregnancy evaluation. A successful term vaginal delivery was achieved with good maternal and perinatal outcomes. CONCLUSION: Selective transfusion of blood products, therapy with prednisone, high-dose i.v. Ig, and intensive fetal surveillance resulted in a successful maternal and perinatal outcome for a pregnancy complicated with aplastic anemia and immune-mediated thrombocytopenia.
机译:背景:再生障碍性贫血在妊娠中很少被描述。病因尚不确定,在妊娠期间禁用骨髓移植的治疗选择。因此,在妊娠期间这种并发症的发生提出了管理上的挑战。并发的免疫介导的血小板减少症使已经很复杂的情况更加复杂。案例:我们的再生障碍性贫血和免疫介导的血小板减少症患者在妊娠晚期被确诊,并用泼尼松/大剂量静脉注射(i.v.)免疫球蛋白(Ig)以及多次输注大量红细胞和血小板输注。胎儿监护包括每周两次无压力测试以及连续的超声检查妊娠评估。成功的足月阴道分娩取得了良好的产妇和围产期预后。结论:血液制品的选择性输注,强的松治疗,大剂量静脉注射免疫球蛋白(Ig)和强化的胎儿监护可成功导致妊娠并发再生障碍性再生障碍性贫血和免疫介导的血小板减少症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号